M&A Deal Summary

Meridien Research Acquires Florida Clinical Research Center

On March 14, 2016, Meridien Research acquired life science company Florida Clinical Research Center

Acquisition Highlights
  • This is Meridien Research’s 1st transaction in the Life Science sector.
  • This is Meridien Research’s 1st transaction in the United States.
  • This is Meridien Research’s 1st transaction in Florida.

M&A Deal Summary

Date 2016-03-14
Target Florida Clinical Research Center
Sector Life Science
Buyer(s) Meridien Research
Deal Type Add-on Acquisition

Target

Florida Clinical Research Center

Maitland, Florida, United States
Florida Clinical Research Center (FCRC) was founded in 1998 by Dr. Andrew Cutler and specializes in research for psychiatric and other central nervous system (CNS) disorders like ADHD, Alzheimer’s dementia, anxiety, bipolar disorder, depression, schizophrenia, insomnia, migraine headache and other pain disorders.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Meridien Research

Winter Park, Florida, United States

Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Meridien Research is a multi-specialty clinical research site company which conducts Phase I-IV inpatient and outpatient clinical trials for global, mid-sized pharmaceutical and biotech sponsors, as well as the largest contract research organizations (“CROs”). Meridien’s research covers more than 50 indications, with the range of therapeutic areas spanning central nervous system, mental health, neurology, metabolic and endocrine disorders and women’s health. Meridien Research was founded in 2000 and is based in Winter Park, Florida.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1